Literature DB >> 19913183

Depression in cancer patients.

Danielle Snyderman1, Daisy Wynn.   

Abstract

Primary care clinicians who care for cancer patients are integral to the recognition, diagnosis, and management of depression in this population. A review of risk factors that may make patients more likely to develop depression can be a useful first step in screening for depression. Several screening instruments may guide clinicians in further work-up of patients suspected of being depressed. Depression is treatable in this patient population and prompt management may have a positive impact on overall outcomes. Pharmacologic and psychotherapeutic treatment options are numerous, and consideration of specific cancer treatments, including side-effect profiles, patient comorbidity, patient preference, and clinician resources, should direct management.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913183     DOI: 10.1016/j.pop.2009.07.008

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  8 in total

1.  Synthesis maps: visual knowledge translation for the CanIMPACT clinical system and patient cancer journeys.

Authors:  P H Jones; S Shakdher; P Singh
Journal:  Curr Oncol       Date:  2017-04-27       Impact factor: 3.677

2.  Identification of Baseline Characteristics Associated With Development of Depression Among Patients With Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Aru Panwar; Katherine Rieke; William J Burke; Harlan Sayles; William M Lydiatt
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-11-01       Impact factor: 6.223

3.  Development and preliminary validation of a short form of the Beck Depression Inventory for Youth (BDI-Y) in a sample of adolescent cancer survivors.

Authors:  Jaime E Blackmon; Cori Liptak; Christopher J Recklitis
Journal:  J Cancer Surviv       Date:  2014-08-28       Impact factor: 4.442

4.  Depression and cardiac disease: epidemiology, mechanisms, and diagnosis.

Authors:  Jeff C Huffman; Christopher M Celano; Scott R Beach; Shweta R Motiwala; James L Januzzi
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-04-07

5.  Microglial Function during Glucose Deprivation: Inflammatory and Neuropsychiatric Implications.

Authors:  Matthew A Churchward; Devan R Tchir; Kathryn G Todd
Journal:  Mol Neurobiol       Date:  2017-02-07       Impact factor: 5.590

6.  Brief Report: Hispanic Patients' Trajectory of Cancer Symptom Burden, Depression, Anxiety, and Quality of Life.

Authors:  Eida M Castro-Figueroa; Normarie Torres-Blasco; Milagros C Rosal; Julio C Jiménez; Wallesca P Castro-Rodríguez; Marilis González-Lorenzo; Héctor Vélez-Cortés; Alia Toro-Bahamonde; Rosario Costas-Muñiz; Guillermo N Armaiz-Peña; Heather Jim
Journal:  Nurs Rep       Date:  2021-06-09

7.  Prevalence Estimates, Severity, and Risk Factors of Depressive Symptoms among Coronary Artery Disease Patients after Ten Days of Percutaneous Coronary Intervention.

Authors:  Sukaina I Rawashdeh; Rasheed Ibdah; Khalid A Kheirallah; Abdullah Al-Kasasbeh; Liqaa A Raffee; Nasr Alrabadi; Iyad S Albustami; Rabia Haddad; Raed M Ibdah; Abdel-Hameed Al-Mistarehi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2021-09-16

Review 8.  Biological Mechanisms of Cancer-Induced Depression.

Authors:  Kimberly Young; Gurmit Singh
Journal:  Front Psychiatry       Date:  2018-07-10       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.